| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9382 |
| Human Intestinal Absorption | HIA+ | 0.9613 |
| Caco-2 Permeability | Caco2+ | 0.6187 |
| P-glycoprotein Substrate | Non-substrate | 0.5742 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6431 |
| Non-inhibitor | 0.9222 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8952 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9188 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8725 |
| CYP450 2D6 Substrate | Non-substrate | 0.9008 |
| CYP450 3A4 Substrate | Non-substrate | 0.6378 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5095 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6335 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8942 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5418 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8763 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5087 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9764 |
| Non-inhibitor | 0.8409 |
| AMES Toxicity | Non AMES toxic | 0.8726 |
| Carcinogens | Non-carcinogens | 0.6469 |
| Fish Toxicity | High FHMT | 0.9331 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9628 |
| Honey Bee Toxicity | High HBT | 0.5146 |
| Biodegradation | Ready biodegradable | 0.6449 |
| Acute Oral Toxicity | IV | 0.7181 |
| Carcinogenicity (Three-class) | Non-required | 0.5744 |